NewAmsterdam Pharma Co. NV (NAMS)

33.95 -0.19 (-0.56%) USD  |  NASDAQ  |  May 19, 13:53
More

NewAmsterdam Pharma EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for NAMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
uniQure NV Upgrade
ProQR Therapeutics NV Upgrade
argenx SE --
Pharming Group NV Upgrade
Arcutis Biotherapeutics, Inc. Upgrade